Letters to the Editor

World Thrombosis Day in Poland, October 14, 2023

Maria Podolak-Dawidziak, Magdalena Łętowska, Jerzy Windyga

Pol Arch Intern Med. 2023, Vol. 133, No. 11: 16598 / DOI: 10.20452/pamw.16598

A fatal course of pancreatic pseudocyst rupture: reflections on the management of the patient. Authors' reply

Agata Janoska-Gawrońska, Marta Pietrukaniec, Milena Kopyś-Sikora, Monika Niezgoda, Michał Holecki

Pol Arch Intern Med. 2023, Vol. 133, No. 10: 16595 / DOI: 10.20452/pamw.16595

A fatal course of pancreatic pseudocyst rupture: reflections on the management of the patient

Edyta Niemiec, Robert Staron, Marcin Krawczyk, Łukasz Krupa

Pol Arch Intern Med. 2023, Vol. 133, No. 10: 16594 / DOI: 10.20452/pamw.16594

Authors’ reply to the letters concerning the article “Effectiveness of the BNT162b2 vaccine in preventing COVID-19–associated deaths in Poland”

Pol Arch Intern Med. 2023, Vol. 133, No. 9: 16575 / DOI: 10.20452/pamw.16575

Effectiveness of the BNT162b2 (COMIRNATY) vaccination in protecting from death due to COVID-19 in Poland: epidemiologic commentary and limitations

Pol Arch Intern Med. 2023, Vol. 133, No. 9: 16574 / DOI: 10.20452/pamw.16574

Bias in data analysis of the study “Effectiveness of the BNT162b2 vaccine in preventing COVID-19–associated deaths in Poland”

Pol Arch Intern Med. 2023, Vol. 133, No. 9: 16573 / DOI: 10.20452/pamw.16573

Indirect insulin resistance markers in relation to nonalcoholic fatty liver disease among patients with type 1 diabetes mellitus. Authors' reply

Agata Grzelka-Woźniak, Aleksandra Uruska, Elektra Szymańska-Garbacz, Aleksandra Araszkiewicz, Maciej Jabłkowski, Leszek Czupryniak, Dorota Zozulińska-Ziółkiewicz

Pol Arch Intern Med. 2023, Vol. 133, No. 7-8: 16553 / DOI: 10.20452/pamw.16553

Indirect insulin resistance markers in relation to nonalcoholic fatty liver disease among patients with type 1 diabetes mellitus

Chun-Chieh Chen, Po-Hui Wang, Chin-Feng Tsai, Yuan-Ti Lee, Shiuan-Chih Chen

Pol Arch Intern Med. 2023, Vol. 133, No. 7-8: 16552 / DOI: 10.20452/pamw.16552

Post-COVID or long-COVID? That is the question. Authors' reply

Giuseppe Lippi, Fabian Sanchis-Gomar, Brandon M. Henry

Pol Arch Intern Med. 2023, Vol. 133, No. 5: 16507 / DOI: 10.20452/pamw.16507

Post-COVID or long-COVID? That is the question

Salvatore Chirumbolo, Umberto Tirelli

Pol Arch Intern Med. 2023, Vol. 133, No. 5: 16506 / DOI: 10.20452/pamw.16506

World Thrombosis Day in Poland, October 15, 2022

Maria Podolak-Dawidziak, Magdalena Łętowska, Jerzy Windyga

Pol Arch Intern Med. 2022, Vol. 132, No. 11: 16361 / DOI: 10.20452/pamw.16361

Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers? Authors' reply

Marek Klocek, Michał Terlecki, Wiktoria Wojciechowska, Marek Rajzer, Tomasz Grodzicki

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16294 / DOI: 10.20452/pamw.16294

Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers?

Dimitrios Patoulias

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16293 / DOI: 10.20452/pamw.16293

Prevalence of aortic stenosis in a large population of patients with heart failure: any insights into comorbid cardiac amyloidosis? Authors' reply

Tomasz M. Rywik, Anna Drohomirecka, Agnieszka Doryńska

Pol Arch Intern Med. 2022, Vol. 132, No. 5: 16263 / DOI: 10.20452/pamw.16263

Prevalence of aortic stenosis in a large population of patients with heart failure: any insights into comorbid cardiac amyloidosis?

Athina Dimosiari, Theodoros Michailidis, Dimitrios Patoulias

Pol Arch Intern Med. 2022, Vol. 132, No. 5: 16262 / DOI: 10.20452/pamw.16262

Can continuous glucose monitoring technology reduce fear of hypoglycemia in people with type 1 diabetes? Authors’ reply

Anna Kłak, Małgorzata Mańczak, Jakub Owoc, Robert Olszewski

Pol Arch Intern Med. 2022, Vol. 132, No. 2: 16210 / DOI: 10.20452/pamw.16210

Can continuous glucose monitoring technology reduce fear of hypoglycemia in people with type 1 diabetes?

Meryem K. Talbo, Tricia Peters, Anne-Sophie Brazeau, Remi Rabasa-Lhoret, Jean-Francois Yale

Pol Arch Intern Med. 2022, Vol. 132, No. 2: 16209 / DOI: 10.20452/pamw.16209

Are mobile applications a solution for the assessment of fatty acid intake? Authors' reply

Aleksander Siniarski, Grzegorz Gajos

Pol Arch Intern Med. 2022, Vol. 132, No. 1: 16188 / DOI: 10.20452/pamw.16188

Will molnupiravir be a game changer in our efforts to safe COVID-19 outpatients?

Jacek Mrukowicz, Bram Rochwerg, Roman Jaeschke

Pol Arch Intern Med. 2022, Vol. 132, No. 1: 16183 / DOI: 10.20452/pamw.16183

Are mobile applications a solution for the assessment of fatty acid intake?

Agnieszka Bzikowska-Jura, Piotr Sobieraj

Pol Arch Intern Med. 2022, Vol. 132, No. 1: 16170 / DOI: 10.20452/pamw.16170

of 11next

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 23 days
acceptance to online first publication, 7 days
acceptance to final publication, 94 days

Current manuscript acceptance rate: 28%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more